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Abstract: Standardized assessment instruments are deemed important for estimating pressure 
ulcer risk. Today, more than 40 so-called pressure ulcer risk assessment scales are available but 
still there is an ongoing debate about their usefulness. From a measurement point of view pres-
sure ulcer (PU) risk assessment scales have serious limitations. Empirical evidence supporting 
the validity of PU risk assessment scale scores is weak and obtained scores contain varying 
amounts of measurement error. The concept of pressure ulcer risk is strongly related to the 
general health status and severity of illness. A clinical impact due do the application of these 
scales could also not be demonstrated. It is questionable whether completion of standardized 
pressure ulcer risk scales in clinical practice is really needed.
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Introduction
Pressure ulcers (PUs) are significant health problems typically occurring in the context 
of severe illness and high care dependency. In their newly developed clinical practice 
guideline, the National Pressure Ulcer Advisory Panel (NPUAP) of the USA and the 
European Pressure Ulcer Advisory Panel (EPUAP) define a PU as “… localized injury 
to the skin and/or underlying tissue usually over a bony prominence, as a result of pres-
sure, or pressure in combination with shear. A number of contributing or confounding 
factors are also associated with pressure ulcers; the significance as these factors is 
yet to be elucidated”.1 This definition clearly indicates that the understanding of this 
complex phenomenon is still limited. There is an ongoing debate about what PUs 
really are, how they develop, and how these lesions should be classified accurately.2–4 
Even the recent international collaboration between NPUAP and EPUAP was unable 
to find a consensus about PU classification.1
Irrespective of these conceptual difficulties, PUs cause serious functional limita-
tions, emotional burden, pain, and impairments for persons affected.5,6 Furthermore, the 
development of PUs in healthcare institutions is regarded as an outcome indicator for 
the quality of care provided.7 PU treatment is expensive and legal issues around PUs 
have become more and more important. Therefore, effective PU prevention plays an 
important role in everyday clinical practice. Recommended strategies include frequent 
repositioning, use of special support surfaces, or providing nutritional support.1
Since the susceptibility to PUs is different from person to person, determination of 
the individual PU risk is important. So-called PU risk scales aim to support   practitioners 
in determining the individual PU risk. The structure of most of these   standardized Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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assessment instruments is comparable: they include a number 
of factors that are deemed important for PU development. 
These factors are operationalized in the form of items, which 
are scored; item scores are then summed, resulting in total 
scores indicating the individual risk level. Cut-off points 
are used to distinguish between “at risk” and “not at risk” or 
among risk levels. Chosen cut-off points or risk categories 
are used to trigger and plan prevention strategies. The very 
first PU risk scale was published by Norton et al in 1962.8 
Other commonly used PU risk scales are the Waterlow9 and 
Braden10 scales. Today, there are more than 40 of these instru-
ments available and new scales are being developed.
PU risk assessment scales are widely used and there are a 
large number of empirical studies about them. However, there 
is an ongoing debate about the usefulness and benefit of PU 
risk scales in clinical practice. PU risk scales are criticized 
for their poor psychometric properties and their inability to 
improve patient outcomes.11–13 In contrast to these arguments 
the latest international clinical practice guideline provided 
by the NPUAP and EPUAP states, “Risk assessment scales 
are the foundation of risk assessment practice”(p. 24).1 How 
can this contradiction be explained? Why is the use of PU 
risk scales debatable? To answer these questions this paper 
provides an overview and discussion of PU risk scale research 
and explores other issues of risk scale application.
Quality of pressure ulcer risk scales
PU risk scales aim to measure and quantify pressure ulcer risk. 
In general, measurement means the assignment of numbers 
to represent the amount of an object, attribute, or trait using 
specified rules. Determining the quality of these measurements 
usually involves evaluation of validity and reliability.
validity
Validity is the degree to which accumulated evidence and 
theory support specific interpretations of test scores entailed 
by proposed uses of a test.14 Authors often distinguish 
between content, criterion, and construct validity but one 
has to keep in mind that these concepts are not clearly sepa-
rable from each other.15 In PU risk scale research all these 
validation approaches were taken into account, but studies 
on diagnostic accuracy that are related to criterion validity 
were most often published.
Content validation
If one wants to measure PU risk, the scale should comprise 
all factors and items that are relevant (content coverage). 
Fulfilling this requirement is challenging. First, there 
are more than a hundred PU risk factors described in the 
literature. Taking both etiological knowledge2,16 and epi-
demiological evidence17–19 into account, factors directly 
causing enhanced exposure to pressure or shearing forces, 
particular restricted mobility, appear to play the most 
important role for PU development. On the other hand, 
in a population where the majority of patients suffer from 
limited mobility (eg, geriatric or intensive care patients) 
this single factor may not be discriminative enough to 
identify patients at increased PU risk. Unfortunately, there 
is no clear-cut evidence on the role of further intrinsic 
(eg, nutrition), iatrogenic (eg, specific medications or 
medical procedures), or behavioral factors (eg, nicotine 
intake) in specific populations.20–22 Available results are 
inconsistent and depend on the population under investiga-
tion as well on methodological issues of respective studies. 
Second, the specific importance of single risk factors is 
not adequately taken into account as long as all items are 
equally weighted.23 PU risk scales considering weights in 
their scores are available, but most often these weights are 
arbitrary, eg, in the Waterlow9 or in the Glamorgan scale.24 
Today, there are only a few PU scales containing weights 
that were developed on a more rational basis, eg, the mul-
tifactorial approach taken by Nonnemacher et al.19
Diagnostic accuracy
Results of diagnostic tests or scores of diagnostic tools must 
be able to identify a condition correctly. Therefore, PU risk 
scales scores must indicate PU risk when there is really a PU 
risk (sensitivity), and they must indicate that there is no risk 
when there is no risk (specificity). Based on obtained sensi-
tivity and specificity, other useful estimates like predictive 
values and likelihood ratios can be calculated. Both sensitiv-
ity and specificity of a test must be high (nearly 100%) to be 
useful in clinical practice.25
Studies on diagnostic accuracy are typically applied to 
investigate this issue. In these investigations, the outcomes 
from one or more tests under evaluation are compared with 
outcomes from the reference standard, both independently 
measured in subjects who are thought to have or not have the 
condition of interest.26 The reference standard is considered to 
provide the best information whether the condition of interest 
is present or absent. Unfortunately, to our best knowledge, 
an unequivocal and approved reference standard for PU 
risk does not exist. Therefore, in a strict sense, diagnostic 
accuracy cannot be investigated because the ‘truth’ cannot 
be observed.27 Nevertheless alternative approaches may 
be taken. In PU risk scale research it is common to use the Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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actual development of PU’s as reference standard to which 
obtained risk scores are compared.
In recent systematic reviews,28–31 diagnostic accuracy 
estimates of more than 30 studies have been identified and 
synthesized. In a meta-analytic approach, Pancorbo-Hidalgo 
et al29 presented pooled sensitivity and specificity estimates 
for the most investigated instruments and concluded that the 
Braden scale shows optimal validation and has the best bal-
ance between sensitivity (57.1%) and specificity (67.5%) as 
compared to the Norton and Waterlow scales. These rather 
low values suggest that Braden scale scores poorly predict 
who will develop a PU and who will not.
On the other hand, due to the influence of PU preventive 
measures, nearly all obtained sensitivity and specificity esti-
mates in PU risk scale research are biased. Applied preventive 
interventions decrease the probability of PU development, 
and sensitivity and specificity as well.32,33 One can also put it 
the other way round: “High sensitivities and specificities can 
only be reached if a study has been conducted in a health care 
institution that does not use effective preventive interventions” 
(p. 40).32 This may be feasible but is clearly undesirable.
In their systematic review Pancorbo-Hidalgo et al29 con-
clude further that the Braden scale score is a good “pressure 
ulcer risk predictor” (OR 4.1, CI 95% 2.6–6.5). This conclusion 
points to another conceptual problem in PU risk scale research. 
First, PU risk can be actually there but the risk cannot be 
predicted. Second, when using PU development as reference 
standard to investigate predictive validity of PU risk scales, 
then obtained risk scores are treated like predictors of who will 
develop a PU and who will not. This is far different from being 
at PU risk.34–36 One can argue that increased PU risk can be 
regarded as an increased probability for PU development, but 
due to the complex nature of PU development and hopefully 
preventive interventions, there is still large uncertainty.
Construct validation
PU ulcer risk scales aim at measuring the highly complex con-
struct “PU risk”. The term “construct validation” is somewhat of 
a tautology because validity almost always refers to constructs14 
but as compared to criterion or content validation, the evaluation 
of construct validity refers to testing the underlying theoretical 
assumptions and it includes a broader set of methodological 
approaches. Three approaches will be discussed: known groups, 
convergent validation, and discriminant validation.
Known groups
Construct validation by known groups is simple: risk scale 
scores are assessed in groups of individuals who are supposed 
to differ in their PU risk level. Then, it is empirically tested 
whether they differ indeed. For example it can be assumed 
that due to higher PU prevalence and incidence rates on 
intensive care units as compared to other specialties37 ICU 
patients are also at much greater PU risk. This assumption 
was confirmed in numerous studies38,39 supporting the con-
struct validity of PU risk scales. However, the known group 
design is a necessary step in instrument validation but it is 
not sufficient.15
Convergent validation
Investigation of convergent validity may include testing how 
closely PU risk scale scores are related to other measures of 
the same construct, eg, other PU risk scales or other ways 
of risk estimation. This approach was taken, for example, 
by Gould et al.40,41 Based on simulated case examples, the 
authors investigated whether scores of the three common 
Norton, Waterlow, and Braden risk scales generated by 
clinical nurses were congruent with the nurses’ own clinical 
judgment assessed on a visual analogue scale (VAS) and with 
the degree of PU risk independently agreed by the consensus 
view of an expert panel. One result was that the nurses’ own 
clinical judgment showed a greater level of agreement with 
expert panel view than assessment with any of the three risk 
scales. The authors concluded that the nurses’ own clinical 
judgment was more likely to give a valid PU risk estimate 
than any of the tested scales.
A comparable study in a clinical practice setting was 
conducted by Kottner and Dassen.42 Two samples of ICU 
nurses rated PU risk according to two scales and according 
to their own clinical judgment on a VAS. Coefficients of 
determination between PU risk scale and VAS scores varied 
between 0.3 and 0.6 indicating that 40% up to 70% of vari-
ances could not be explained by score differences. In other 
words, the same construct of PU risk was only partly covered 
by the three measures.
Discriminant validation
Since all PU risk scales are expected to measure the same 
construct, obtained scores can be expected to correlate with 
each other. On the other hand, they should not be related to 
scores of dissimilar or unrelated constructs. Since PU risk 
and PU development are complex phenomena it seems nearly 
impossible to decide what health problem or condition is not 
related to PU risk. In fact, empirical evidence suggests that 
PU risk is indistinguishable from general health status. For 
example, two studies showed that a scale measuring overall 
care dependency performs equally in identifying patients at Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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PU risk as compared to PU risk assessment scales.43,44 Similar 
results were found when the diagnostic performance of the 
Minimum Data Set of the Resident Assessment Instrument 
was compared to that of the Braden scale in long-term care.45 
There are strong associations between Braden scale and 
Glasgow Coma Scale scores,46 and Palliative Performance 
Scale scores.47 Capon et al identified statistically significant 
relationships between factors such as previous stroke, previ-
ous trauma, and cognitive decline and PU risk, according to 
the Braden scale.48
Reliability and agreement
The terms reliability and agreement are often used inter-
changeably but they are conceptually distinct. Reliability 
can be defined as the ability of scores of a test or scale to 
differentiate among subjects or objects, and agreement is 
the degree to which scores or ratings are identical.49 Both 
concepts are important since they provide information about 
the amount of error inherent in scores and measurements 
and therefore they determine the upper limit of the validity 
of any measurement.50,51
In PU risk scale research, various ways of determining 
reliability and agreement were used and therefore the results 
are hardly comparable. Two reviews found that there is 
little empirical evidence regarding inter-rater reliability and 
agreement of the Braden and Waterlow scales when used in 
clinical practice.52,53 Systematic synthesis of reliability and 
agreement estimates of other PU risk scales is lacking.
Recent study results suggest that there are considerable 
differences regarding the amount of measurement error of 
individual items, indicating that some items are much harder 
to rate than others.42,54 This may be explained by ambiguous 
wording of some items, the qualification and training of rat-
ers, or by properties of the rated subjects.23,55 Additionally it 
could be shown that despite high inter-rater reliabilities for 
total scores, the probability of exact agreement among users 
of PU risk scales in clinical practice is low. For instance, 
when applying the Braden scale total score in nursing home 
and home care settings, differences of up to 3 or more points 
can be expected.55,56 Finally, scale scores that proved to be 
somewhat reproducible in one care setting may perform poor 
in another setting.42 This indicates that reliability and agree-
ment coefficients like sensitivity and specificity measures 
are population specific.
Clinical impact
Investigations of validity and reliability are important 
in evaluating the quality of PU risk scales but they are 
  insufficient to judge their clinical value. Results of diagnostic 
tools should be used to guide interventions and to improve 
patient outcomes important to patients.57 Randomized con-
trolled trials in which investigators randomize patients to 
groups using different diagnostic approaches are the best 
way to assess the clinical impact of diagnostic strategies58 
but quasi experimental or observational studies may also 
provide some information.
empirical evidence
In PU research only few attempts have been made to compare 
different PU risk assessment strategies. Looking at the litera-
ture until 2003, Pancorbo-Hidalgo et al in their systematic 
review29 identified three studies investigating the impact of 
using the Norton scale compared to clinical judgment on PU 
incidence. They concluded that there was no evidence that 
the use of risk assessment scales decreased pressure ulcer 
incidence. The objective of a recent Cochrane review was to 
determine whether using PU risk assessment, in any health 
care setting, reduces the incidence of pressure ulcers. Since 
no studies met the inclusion criteria the authors were unable 
to answer their review question.59
In a controlled trial, Vanderwee et al60 compared two 
diagnostic strategies for PU prevention: one group of patients 
received preventive measures (support surface, turning) 
when Braden scale scores were less than 17, and in the other 
group prevention was started when nonblanchable erythema 
(Category 1 PU) appeared. In the end there was no statisti-
cally significant difference regarding PU incidence in the 
two groups. Furthermore, since more preventive interven-
tions were conducted in the “risk scale group”, the authors 
concluded that using nonblanchable erythema instead of the 
Braden scale score would lead to a considerable reduction 
of preventive measures without resulting in an increase in 
pressure ulcers.
In a smaller quasi-experimental study, Saleh et al61 
compared three patient groups of one hospital: the Braden 
scale was used in one group, including an intensive educa-
tion and training program. Another group received the same 
program without implementing the Braden scale; and a 
third group performed as usual including standard ongoing 
education. PU frequency reduced in all three groups with no 
significant differences. The authors concluded that clinical 
judgment may be as effective as using a PU risk scale in 
determining appropriate care.
Finally, based on a comparison between 16 nursing 
homes with very high and very low PU prevalence rates, 
Bates-Jensen et al62 were unable to detect any differences in Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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the use of PU risk scales. In other words, PU care was not 
better when PU risk scales were used.
Opinions
Irrespective of study results, the main goal of PU risk 
scales is to predict who will develop PUs for the purpose 
of planning effective prevention strategies.34,63 There is the 
idea that the main benefit of PU risk scales lies in its acting 
as a reminder to nurses about possible PU development. 
PU risk scales aim at increasing the awareness of factors 
contributing to PU risk for practitioners.9,33 Recently, it was 
argued that scores of single PU risk items provide informa-
tion for planning preventive measures, and are more able 
to guide clinical practice than broad risk categories or sum 
scores.30,63,64 Scales should be used as a kind of checklist 
leading to specific preventive interventions. For example, 
when there are restrictions regarding mobility or activity, 
pressure reducing surfaces or repositioning schedules should 
be applied. Likewise, special skin care and cleansing are 
required when the risk assessment reveals a problem with 
skin moisture.65,66
Although each of these arguments for use of PU risk 
scales sounds reasonable it has to be noted that they are 
based on opinion rather than scientific evidence. Well-
conducted studies which investigate the impact of the use 
of any PU risk assessment instrument on nurses’ clinical 
decision making are still lacking. In a small mixed-methods 
study67 conducted in a long-term care setting, both the 
assessment of patients’ PU risk, and the allocation of pre-
ventive interventions, appeared to be marginally guided 
by the information provided by use of the Waterlow scale. 
Instead, it was observed that nurses changed the total 
scores so that they matched the patients’ PU risk as per-
ceived by them. Similarly, alterations of the Waterlow sum 
scores were often not followed by an adaption of the care 
plan. Thus, based on these results the author questioned 
“... whether assessment tools such as the Waterlow scale 
add anything more to the knowledge that a nurse has of an 
older person ...”(p. 38).67
Other considerations
So far two important properties of PU risk scales were 
addressed. However, there are some other areas in health care 
where PU risk scales may play an important role.
Legal issues
Litigation against healthcare providers is increasing and 
PU development is an increasing reason for lawsuits.68–70 
From the legal perspective comprehensive documentation 
is of utmost importance because in court it is argued “what 
was not documented was not done”.71 This is also true 
for PU prevention. Continuing documentation of PU risk 
scale scores is used as evidence that a PU risk assessment, 
as the first necessary step in the prevention process, was 
performed.72
Research
PU risk scale scores are used as case-mix adjuster when 
making comparisons of PU incidence or prevalence 
measures between units, institutions, or even countries. 
Stratification according to a specified cut-off point enables 
adequate comparisons of different samples.39,73–75 Total 
or item scores are used in multivariate models to adjust 
for PU risk,76,77 and in clinical trials comparing different 
preventive interventions item and total scores are used as 
eligibility criteria.78,79
Quality assurance
Institutions and professionals are required to provide high qual-
ity care. Among others, the outcome of having developed PU is 
regarded as one indicator of the quality of pressure ulcer preven-
tion,80 but recently it was argued that the measurement of PU 
occurrence per se has hardly any beneficial effect.81 Instead, one 
should focus on the whole process of PU prevention including 
the risk assessment. PU risk assessment on admission could be 
used as an auditable quality indicator.81,82 For example Duncan 
proposed to use the proportions of completed risk assessments 
using validated PU risk scales as a quality indicator. Proportions 
of patients with completed PU risk assessment on admission 
or the proportions of patients reassessed daily could be used.83 
The number of completed PU risk assessments using a PU risk 
scale was also used as an audited quality indicator by a team 
of Canadian nurses in a pediatric setting.84
Discussion
Evaluation of PU risk scales can be performed from differ-
ent perspectives: (1) from the measurement point of view, 
(2) from the clinical impact point of view, and (3) based on 
other practical considerations.
Quality of PU risk scale scores
When focusing on classical measurement theory then it is 
apparent that the evidence supporting validity and reliabil-
ity of PU risk scale scores is inconclusive. Without doubt, 
PU risk scale scores are related to the probability of PU 
  occurrence and therefore they are also somehow related to Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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PU risk. Perhaps this association makes one imagine that PU 
risk scales work,85 but when going more into detail major 
drawbacks become apparent.
First of all, while there is a large number of PU risk 
factors described in the literature, the underlying evidence 
is inconsistent and varies depending on the population and 
factors taken into consideration. Thus, the content validity 
of PU risk scales is debatable. Although there are some risk 
factors that are included in nearly every scale (eg, mobility) 
there are many more factors that are not included, included 
in some scales only, or are not adequately weighted. Second, 
using PU development as a reference standard is inappropri-
ate when computing diagnostic accuracy as long as the effect 
of prevention is not adequately taken into account. Therefore 
results of most diagnostic accuracy studies are limited. Third, 
results of construct validity studies are sparse but they reveal 
that the concept of PU risk is hardly separable from general 
health. One can also put it the other way round: PU risk 
scales do not measure PU risk but the degree of functional 
impairments and general care dependency. This finding is 
not surprising because most factors included in PU risk 
scales are similar to items of other measures of basic human 
functioning like the Activities of Daily Living (ADL) index86 
or the Functional Independent Measure (FIM).87
Results from reliability and agreement studies are difficult 
to interpret. Although total scores proved to be reliable in some 
care settings, it is very unlikely that exact agreement will be 
achieved in clinical practice. Therefore, scale users must decide 
whether disagreements are clinically acceptable. It depends on 
the purpose and consequences of obtained risk scale scores how 
much error will be allowed to be introduced into clinical deci-
sion making. This challenges especially the use of rigid cut-off 
points and risk categories. There are various examples in the 
literature and clinical practice where measurement errors are not 
adequately addressed. For example, a Braden scale score of 18 
or less is often used to trigger special PU preventive interven-
tions or applications of pressure relieving devices.88,89 Given 
that the inter-rater reliability was high in the settings using this 
cut-off point, say .0.9, then score differences of up to 3 can be 
expected. Consequently, there is no reason to exclude patients 
with Braden scale scores of 20 from this regime.
Today, the validity and reliability limitations of PU risk 
scales are widely acknowledged. To deal with these problems 
the solution that was often recommended was to combine 
scores of PU risk scales with clinical judgment.1 Unfortunately, 
this recommendation, albeit often seen in the literature, is logi-
cally inconsistent because as Papanikolaou et al23 put it: “If PU 
risk assessment scales have such limitations, what contribution 
can they make to our confidence in clinical judgment, other 
than prompting us about the items, which should be considered 
when making such judgments?” (p. 294).
Clinical benefit
As of today, there is no evidence that PU prevention is more effective 
if PU risk scales were used. If PU risk scales are regarded primarily 
as ‘aide memoires’ then why should one not rather use simpler but 
perhaps more comprehensive forms of reminders instead of com-
pleting time consuming scales? There may be other, and perhaps 
more effective, ways of increasing the awareness of the PU problem 
in health care, eg, continuous monitoring of PU prevalence or inci-
dence, staff involvement in PU studies, and education.33,61,90
Other considerations
Without doubt documentation of diagnostic and therapeutic 
interventions is not only important for multidisciplinary 
communication but also for reimbursement, quality assur-
ance, and protection against lawsuits. However, based on the 
described limitations we doubt if using and documenting PU 
risk scores can satisfy these additional requirements. If PU 
risk assessment based on standardized scales is hardly valid 
and precise, and if scale use does not lead to a reduction in 
PU frequency, how can these tools improve clinical care?
Conclusion
Empirical evidence supporting the validity of PU risk assess-
ment scale scores is weak and obtained scores contain varying 
amounts of measurement error. A clinical impact due do the 
application of these scales could not be demonstrated. These 
issues should be seriously taken into account whenever such 
instruments are applied in clinical practice. Since PU risk is 
strongly related to the general health status and severity of 
illness, it is questionable whether an additional completion of 
standardized PU risk scales is really needed. There is no rationale 
to use PU risk scales as a quality indicator for care processes.
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